论文部分内容阅读
目的分析匹多莫德治疗小儿呼吸系统反复感染的临床疗效。方法对照组患儿给予常规临床治疗措施,内容包括吸氧、改善肺部微循环、镇静、解痉、布地奈德给药等;研究组患儿在常规治疗基础上增加匹多莫德口服液联合治疗。结果研究组治疗有效患儿所占比例高达93.94%,显著高于对照组78.79%;研究组治疗无效患儿所占比例仅为6.06%,显著低于对照组21.21%,对比结果具有统计学意义(P<0.05)。结论应用匹多莫德联合常规治疗措施,可显著提高呼吸系统反复感染患儿临床治疗总有效率,改善其临床表现及降低患儿再次感染发生率,保障患儿预后及生活质量,值得临床推广应用。
Objective To analyze the clinical efficacy of pidotimod in the treatment of recurrent respiratory infections in children. Methods The control group of children given conventional clinical treatment measures, including oxygen, improve pulmonary microcirculation, sedation, antispasmodic, budesonide administration; study group children in the conventional treatment based on the increase of pidotimod oral solution Combination therapy. Results The proportion of effective treatment children in the study group was as high as 93.94%, significantly higher than 78.79% in the control group. The proportion of children with ineffective treatment in the study group was only 6.06%, which was significantly lower than that of the control group (21.21%), and the results were statistically significant (P <0.05). Conclusion Combined use of pidotimod and conventional treatment can significantly improve the total effective rate of clinical treatment of children with recurrent respiratory infections, improve their clinical manifestations and reduce the incidence of re-infection in children to protect the prognosis and quality of life in children worthy of clinical promotion application.